We had previously shown loss of DNA methylation for a CpG island spanning the human DNMT3L promoter/exon1 region (promoter for DNMT3L variant 2 and first exon in case of DNMT3L variant 1) for cervical and ocular cancer samples [16], [17]. Here, DNMT3L is linked to ocular cancer.